Search Within

Virginia Klimek

Formats
  1. Meeting Abstract (78)
  2. Journal Article (64)
  3. Editorial (2)
  4. Research Letter (2)
  5. Book Section (1)
Groups
  1. Adult Leukemia (147)
  2. Center for Hematologic Malignancies (147)
  3. Department of Medicine (147)
  4. Hematologic Malignancies, Division of (147)
  5. GSK Faculty (44)
  6. Epidemiology and Biostatistics (36)

More Groups

People
  1. Stephen Nimer (30)
  2. Sean Devlin (26)
  3. Martin Tallman (22)
  4. Ross Levine (21)
  5. Stephen Chung (18)
  6. Elli Papaemmanuil (14)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (8)
  6. 2019 (14)

More Years

Publications
  1. Blood (54)
  2. Leukemia Research (10)
  3. Journal of Clinical Oncology (9)
  4. Haematologica (8)
  5. Bone Marrow Transplantation (4)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (54)
  2. Nature Publishing Group (17)
  3. American Society of Clinical Oncology (10)
  4. Elsevier Ltd (10)
  5. Ferrata Storti Foundation (8)
  6. American Association for Cancer Research (6)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Maitake mushroom extract in myelodysplastic syndromes (MDS): A phase II study
    Journal Article

    Wesa, K. M.; Cunningham Rundles, S.; Klimek, V. M.; Vertosick, E.; Coleton, M. I.; Yeung, K. S.; Lin, H.; Nimer, S.; Cassileth, B. R.
    Cancer Immunology, Immunotherapy (2015)

    Fulltext@MSK | Save
  • Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes
    Journal Article

    Efficace, F.; Gaidano, G.; Breccia, M.; Criscuolo, M.; Cottone, F.; Caocci, G.; Bowen, D.; Lùˆbbert, M.; Angelucci, E.; Stauder, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Mutation profiling of therapy-related myeloid neoplasms using next-generation sequencing demonstrates distinct profiles from de novo disease
    Meeting Abstract

    Shih, A. H.; Rapaport, F.; Chung, S. S.; Dolezal, E. K.; Hobson, S.; Amato, M. K.; Park, C. Y.; Sekeres, M. A.; van den Brink, M. R. M.; Nimer, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Improved survival in patients with first relapsed or refractory acute myeloid leukemia (AML) treated with vosaroxin plus cytarabine versus placebo plus cytarabine: Results of a phase 3 double-blind randomized controlled multinational study (VALOR)
    Meeting Abstract

    Ravandi, F.; Ritchie, E.; Sayar, H.; Lancet, J.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G.; Jabbour, E.; Erba, H. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • CD99 is a therapeutic target on disease initiating stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S. S.; Tavakkoli, M.; Klimek, V. M.; Park, C. Y.
    Blood (2014)

    Fulltext@MSK | Save
  • Cd99 is a stem cell marker and therapeutic target in aml/mds
    Meeting Abstract

    Chung, S. S.; Devlin, S. M.; Klimek, V. M.; Melnick, A.; Park, C.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Leukemias and myelodysplastic syndromes
    Book Section

    Watts, J. M.; Klimek, V. M.; Tallman, M. S.; Douer, D.; Olson, A. L.; Berman, E.; Intlekofer, A. M.; Zelenetz, A. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Cd99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes
    Meeting Abstract

    Chung, S.; Klimek, V.; Park, C.
    Experimental Hematology (2014)

    Fulltext@MSK | Save
  • CD99 is a diagnostic and therapeutic target on disease stem cells in MDS and AML
    Meeting Abstract

    Chung, S. S.; Pang, W. W.; Devlin, S.; Klimek, V. M.; Melnick, A.; Park, C. Y.
    Modern Pathology (2014)

    Fulltext@MSK | Save